JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,000 | -11.9% | 8,631 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $98,806 | -1.4% | 8,324 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $100,212 | -6.3% | 8,282 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $106,914 | -2.8% | 8,118 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | +12.2% | 8,147 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $98,000 | -22.2% | 8,032 | -8.9% | 0.00% | 0.0% |
| Q1 2022 | $126,000 | -9.4% | 8,813 | +25.3% | 0.00% | 0.0% |
| Q4 2021 | $139,000 | -11.5% | 7,031 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | – | 7,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |